arginase-1 peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-011226
A vaccine comprised of arginase-1 peptides, with potential antineoplastic activity. Upon vaccination, the arginase-1 peptide vaccine may activate the immune system to induce an immune response against arginase-1-expressing cells. Arginase-1 is expressed by some cancer cells and by immune inhibitory cells, such as myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs); its expression is associated with poor prognosis.
| Identifier | MLC-T-ONC-011226 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ARG-1 peptide vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011226",
"term": "arginase-1 peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A vaccine comprised of arginase-1 peptides, with potential antineoplastic activity. Upon vaccination, the arginase-1 peptide vaccine may activate the immune system to induce an immune response against arginase-1-expressing cells. Arginase-1 is expressed by some cancer cells and by immune inhibitory cells, such as myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs); its expression is associated with poor prognosis.",
"synonyms": [
"ARG-1 peptide vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/arginase-1-peptide-vaccine/"
}
Record 2,422 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.